Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Osteoporosis drugs 'reduce breast cancer risk'

  • Comment

Medication commonly used to treat osteoporosis could reduce the risk of breast cancer by more than a third, research has found.

Scientists in the US found that bisphosphonates, usually prescribed for brittle bones, cut the cancer risk by almost 40% among those who had been using them for two years or more.

The research, which compared more than 3,000 breast cancer sufferers to those without the disease, found a strong association between the treatment and a reduced breast cancer risk, also finding that prolonged exposure to bisphosphonates appeared to further reduce the chance of contracting the cancer.

Study leader Dr Polly Newcomb, from the Fred Hutchinson Cancer Research Centre in Seattle, Washington, said: “These medications inhibit the growth of many cell types, and this large study suggests that the development of breast tumours may also be affected.”

The results were published in the British Journal of Cancer.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs